Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
==== TRAP-seq ==== TRAP-seq is used to identify mRNAs being actively translated in a specific cell type within a tissue or other assortment of cells. The cell type of interest is engineered to express a ribosomal subunit fused to an epitope tag such as green fluorescent protein. After cell lysis, antibodies targeting the epitope are used to isolate mRNAs that are bound to the ribosomes containing the fusion proteins. This RNA is then converted to cDNA and sequenced. This technique specifically identifies mRNAs that are being translated in the cell type of interest.
Phenazopyridine produces a vivid color change in urine, typically to a dark orange to reddish color. This effect is common and harmless and indeed a key indicator of the presence of the medication in the body. Users of phenazopyridine are warned not to wear contact lenses, as phenazopyridine has been known to permanently discolor them. Furthermore, it tends to leave an orange-yellow stain on surfaces (including fabrics) it comes in contact with. These color changes can be concerning for patients, who may mistake them for the presence of blood in the urine. Phenazopyridine can cause headaches, upset stomach (especially when not taken with food), or dizziness. Less frequently it can cause a noticeable yellowish pigment change in the skin or eyes. This is due to a depressed excretion via the kidneys causing a buildup of the medication in the skin, and normally indicates a need to discontinue usage. Other such side effects include fever, confusion, shortness of breath, skin rash, and swelling of the face, fingers, feet, or legs. Long-term use may cause yellowing of nails. Phenazopyridine should be avoided by people with glucose-6-phosphate dehydrogenase deficiency, because it can cause hemolysis (destruction of red blood cells) due to oxidative stress. It has been reported to cause methemoglobinemia after overdose and even normal doses. In at least one case, the patient had pre-existing low levels of methemoglobin reductase, which likely predisposed her to the condition. It has also been reported to cause sulfhemoglobinemia. Phenazopyridine is an azo dye.
== Definition of obesity == Obesity is defined as a person having excess body fat. Obesity can be measured in different ways, but most common is the Body Mass Index (BMI) which is calculated based on a person's height and weight.
== Somatostatin receptor antagonists in radiolabelling == These compounds work by binding to somatostatin receptors, which are more common in specific types of tumours. It does not activate the receptor. Due to the radionuclide, it will appear on PET scans. The radiolabeled somatostatin receptor antagonists share the following structure. The antagonist has a peptide moiety, and is responsible for receptor recognition and antagonist activities. Nomenclature is based on Radionuclide-Chelator-Receptor Antagonist.
Sources: en.wikipedia.org
Considered one of the most effective forms of reversible birth control Can be used while breastfeeding (see also nursing mothers) No preparations needed before sex, though routine checking of the device strings by patient and physician is advised to ensure proper placement remains intact 90% of users who wish to become pregnant do so within 24 months of removal. May experience lighter periods (some users stop having periods completely, see also amenorrhea) Effective for up to three to eight years (depending on the IUD) Disadvantages:
"Absinthe's second coming" Archived 2008-12-03 at the Wayback Machine – An April 2001 article in Cigar Aficionado about the first absinthe commercially produced in France since the 1915 ban. "Swiss face sobering future after legalizing absinthe" Archived 2016-12-02 at the Wayback Machine – A March 2005 Reuters article about the legalising of absinthe in Switzerland. "The Mystery of the Green Menace" – A November 2005 Wired magazine article about a New Orleans man who has researched the chemical content of absinthe and now distills it in France "The Return of the Green Faerie" – A wine and spirit journal article about the history, ritual, and artistic cult of absinthe The Wormwood Society Archived 2006-04-24 at the Wayback Machine – An independent organisation supporting changes to the US laws and regulations concerning absinthe. Provides articles, a forum and legal information. "What Is Absinthe" – Article discussing absinthe and its effect over mind and body. Absinthe in the online Culinary Heritage of Switzerland database.
The tear film is composed of three layers: the lipid, aqueous, and mucin. These play a role in creating a smooth surface to facilitate refraction, lubricating the movement of the eyelid, passively transporting gases such as oxygen and carbon dioxide, and protecting the cornea. This last function is achieved through functions of various layers within the tear film. Tears bathe corneal epithelial cells in a moist environment, preventing them from drying out and weakening. However, the liquid layer of the tear film also contains antimicrobial properties resulting from the presence of lysozymes, lactoferrins, lipocalin, and beta-lysine, which facilitate pathogen defenses such as lysis of bacterial cell walls, prevention of bacterial and viral binding, inflammation, and detoxification. Furthermore, white blood cells can be transported to the corneal surface via the tear film, and both toxic agents as well as debris can be diluted and washed away by the tear film. The tear film also contains immunoglobulins, especially IgA, which is found in concentrations significantly higher than in serum. IgA has been shown to prevent bacterial binding. Along with another immunoglobulin present in the tear film, IgG, IgA can also neutralize viruses and bind to bacteria, aiding in their detection via other pathways.
==== Combination formulations ==== Adapalene/benzoyl peroxide (CD-0271/CD-1579; Epiduo; GK-530G; Tactuo; TactuPump) – combination of adapalene (retinoid) and benzoyl peroxide (undefined mechanism of action) Adapalene/benzoyl peroxide/clindamycin phosphate (Cabtreo; IDP-126) – combination of adapalene (retinoid), benzoyl peroxide (undefined mechanism of action), and clindamycin phosphate (lincosamide antibiotic) Benzoyl peroxide/clindamycin (Duac) – combination of benzoyl peroxide (undefined mechanism of action) and clindamycin (lincosamide antibiotic) Benzoyl peroxide/clindamycin low dose (Acanya; BenzaClin; Clin-BPO; Onexton) – combination of benzoyl peroxide (undefined mechanism of action) and clindamycin (lincosamide antibiotic) Benzoyl peroxide/tretinoin – combination of benzoyl peroxide (undefined mechanism of action) and tretinoin (retinoid) Clindamycin/tretinoin (Acnatac; Acnex; CLin-RA; Ziana) – combination of clindamycin (lincosamide antibiotic) and tretinoin (retinoid) Ethinylestradiol/drospirenone low-dose (Yasmin, Yaz) – combination of ethinylestradiol (estrogen) and drospirenone (progestogen) and a combined oral contraceptive Ethinylestradiol/drospirenone/levomefolic acid (BAY98-7071; Beyaz; Safyral; Yasmin Plus; Yaz Flex Plus; Yaz Plus) – combination of ethinylestradiol (estrogen), drospirenone (progestogen), and levomefolic acid (vitamin B9) and a combined oral contraceptive
==== X-ray ==== X-rays are produced by bombardment of dense target material with high-energy accelerated electrons (this process is known as bremsstrahlung-conversion), giving rise to a continuous energy spectrum. Heavy metals, such as tantalum and tungsten, are used because of their high atomic numbers and high melting temperatures. Tantalum is usually preferred over tungsten for industrial, large-area, high-power targets because it is more workable than the latter and has a higher threshold energy for induced reactions. Like electron beams, X-rays do not require the use of radioactive materials and can be turned off when not in use. X-rays have high penetration depths and high dose uniformity but they are a very expensive source of irradiation as only 8% of the incident energy is converted into X-rays.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.